Investing & Dividends Half-true — works only if you do the unspoken work

By the Income Reality Check Editorial Team · Updated 2026-05-20 · 7 min read

ZipTrader’s “buy heavy before June” 5 stocks: what the pitch skips

Verdict: Half-true — works only if you do the unspoken work. The catalysts behind each pick are real news. The “buy heavy” framing, the position sizing, and the paid biotech tacked onto the end are where the video stops being analysis and starts being a sales pitch.

A YouTube channel called ZipTrader, fronted by a host nicknamed Charlie, just published a video titled “5 Stocks To BUY HEAVY Before June 2026.” At 94,592 views and climbing, it walks viewers through USA Rare Earth, CoreWeave, Nebius, Marathon Digital, and NuScale Power — five names tied to real, datable news events the host says will move them in the next six to eight weeks. He then closes with a sponsored segment for a small-cap biotech called Quantum BioPharma. The five-name thesis isn’t crazy. The framing around it is the problem.

What the video actually claims

The host argues that each of the five companies is sitting on a “narrative” catalyst that’s about to fire. USA Rare Earth (USAR) is positioned as a beneficiary of Trump-era critical-minerals policy, with a Department of Commerce letter of intent worth roughly $1.6 billion in proposed grants and senior loans plus an equity stake the federal government would hold. CoreWeave (CRWV) is sold as the cleanest play on the AI infrastructure buildout, with Meta, Nvidia, OpenAI, Anthropic, and Jane Street all named as customers or investors. Nebius (the host calls the ticker “NBIX,” though the correct symbol is NBIS) is framed as a CoreWeave with four extra businesses bolted on, including self-driving and European AI sovereignty.

Marathon Digital (MARA) is pitched as a Bitcoin miner mid-pivot into AI compute via a joint venture with Starwood Digital Ventures, with up to 90% of its mining capacity convertible to AI workloads. NuScale (SMR) is described as the only U.S. company with an NRC-approved small modular reactor design, ready to ride the AI-power-demand wave plus a SpaceX-IPO halo trade.

Then comes the sponsored block: Quantum BioPharma (QNTM), a clinical-stage biotech with a multiple sclerosis candidate called Lucid-MS, plus a separate royalty interest in a hangover-cure brand and a federal securities lawsuit seeking $700 million. The host discloses it’s “our sponsored segment,” but doesn’t disclose how much ZipTrader was paid, which is the disclosure that actually matters under U.S. securities law.

What the method actually requires

Almost every concrete claim in the video checks out. Meta did expand its CoreWeave commitment by $21 billion in April 2026, bringing the relationship to about $35 billion through 2032, as CNBC reported and Bloomberg confirmed. USA Rare Earth’s $1.6 billion CHIPS-program LOI and the government’s share-and-warrant package are laid out in the company’s own SEC filings from January 2026. MARA did sign a Starwood JV in February 2026, and the stock did pop on the announcement. NuScale really does hold an NRC design certification — the only U.S. SMR design that does.

So where’s the half-truth? It’s in everything around those facts.

Take CoreWeave. Yes, the customer pipeline is massive. But the same SEC filings show Microsoft accounted for roughly 62% of 2024 revenue, and a single customer (likely Microsoft again) sat at 71% in Q2 2025. That’s not diversification — it’s a hostage situation dressed in a multi-customer headline. The Meta deal helps, but CoreWeave has also raised about $20 billion in capital this year alone, much of it debt, to keep building the data centers those customers will rent. If hyperscaler AI spend cools even slightly, that capital stack gets ugly fast.

Take NuScale. The “first to NRC certification” line is true. What the video doesn’t mention: NuScale’s flagship commercial project — the Carbon Free Power Project with Utah Associated Municipal Power Systems — was cancelled in November 2023, per a joint announcement filed with the SEC. Costs had climbed to $89 per megawatt-hour and subscribers walked away. The host says SMR’s “first commercial reactor isn’t going to be online until 2029 and 2030,” which is technically what NuScale is now guiding to with newer partners — but the previous 2029 target evaporated, and that history matters when you’re being asked to “buy heavy.”

Take USAR. The federal funding is real but explicitly contingent on “achieving certain project, financing and commercial milestones” before any money flows. The LOI is non-binding. Mining projects, as the host himself admits in a single throwaway line, “always take a lot longer than companies say they will.”

And take the QNTM segment. U.S. securities rules — specifically Section 17(b) of the Securities Act — require that anyone promoting a stock for compensation disclose both that they were paid and the amount and form of payment. “This is our sponsored segment” satisfies half of that. The amount and form aren’t disclosed. The SEC has actively prosecuted social-media stock promoters for failure to make full disclosures, including the December 2022 charges against eight Twitter and Discord influencers in a $100 million pump-and-dump tied to Atlas Trading. ZipTrader isn’t accused of anything similar, to be clear. But the standard a regulator would apply is higher than what the video meets.

Who actually wins this game?

Stock-picking content like this rewards three groups, and retail viewers aren’t reliably one of them.

The first group is institutions and prop desks who already own positions in these names and benefit when retail attention drives short-term volume. The second is the channels themselves, monetized through ads, sponsorships, and (in many cases) paid education products. The third is genuinely well-prepared individual traders with strict position sizing, stop losses, a multi-year horizon, and a willingness to be wrong on four out of five picks. None of those three look like a 25-year-old watching a 14-minute video on a Tuesday night and clicking buy at the open.

Morningstar’s data on active management is the cleanest benchmark here: only about 38% of active funds survived and outperformed a comparable passive fund in 2025, and the ten-year survival-plus-outperformance rate is well under a quarter. Those are professional money managers with research teams. A retail viewer attempting to replicate a five-name concentrated bet from a YouTube video is operating with less information and worse risk tools than the active managers who already lose to the index most years.

What you’d realistically earn

There is no honest, single-number answer to “what will these five stocks return by June.” Anyone who gives you one is guessing.

What can be said with sourcing: each of these five names is what professionals call a speculative position. They trade on story, not earnings. Their price moves can be 5-15% in a single session on a single headline. CoreWeave has whipsawed on Nvidia earnings days; MARA tracks Bitcoin even after the AI pivot; NuScale has done multi-hundred-percent round trips on policy news; USAR is a thinly traded post-merger name with a government overhang. A reasonable framework — one almost every wealth advisor would echo — is to cap speculative positions at 5 to 10% of a total portfolio in aggregate, not per name. The host’s “buy heavy” phrasing implies the opposite.

If you bought equal-weighted into all five today and held to June 2026, you might be up 30%. You might be down 30%. The video itself, in its risk disclaimers, says exactly that — “if you’re the one taking the ultimate risk, you got to be the one doing the ultimate” research — but the thumbnail and title sell the opposite emotion. That gap between the headline and the disclaimer is the heart of the half-truth.

Who this is (and isn’t) for

This kind of content can be useful if you already have a diversified core portfolio (index funds, a healthy emergency fund, no credit-card debt), a defined speculative budget you’ve agreed with yourself, and the patience to be wrong without it affecting your rent. In that profile, narrative-driven names like SMR or USAR are reasonable lottery tickets — sized like lottery tickets.

It is not for you if these would be your first stock purchases, if you’d have to borrow to buy them, if “buy heavy” sounded like permission, or if you’d be checking the price every hour. The structural reasons retail investors underperform — concentration, overtrading, recency bias, selling losers late and winners early — get worse, not better, when the source is a confident YouTube host with a sponsor segment at the end.

If you’re outside the U.S., one more caveat. ZipTrader’s framing leans on U.S. policy catalysts (Trump executive orders, Pentagon contracts, CHIPS Act money). Those don’t translate one-for-one to U.K., EU, Canadian, Indian, or Australian portfolios, and your local regulator — the FCA, ESMA, OSC, SEBI, or ASIC — applies a different rulebook to financial promotions than the SEC does.

What to remember

The five companies in this video are real, the catalysts named are real, and the host is more honest about narrative-vs-fundamentals trading than most. He just buries that honesty under a “BUY HEAVY” thumbnail and a paid biotech segment whose compensation amount isn’t disclosed. Treat the list as a research starting point. Don’t treat it as a portfolio.

For more of the same genre, see our breakdown of an earlier ZipTrader-style pitch from May 2026 and an even more urgent variant titled 6 stocks you must buy now.

View counts and stock prices referenced in this review reflect the moment of writing and will have moved by the time you read this.